MYCN and neuroblastoma: Consistent with its anti-apoptotic function, the increased levels of ΔNp73 expression are significantly associated with poor survival in patients with neuroblastomas, whereupon it predicts worse outcome independently of other risk factors such as patient age and MYCN amplification [46].